Dr. Georgiana Dobri, a neuroendocrinologist with Weill Cornell Medicine, discusses the approval of osilodrostat and management of Cushing's disease in 2020.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
